Xian Lin Li

Presidente presso China National Pharmaceutical Industry Corp. Ltd.

Patrimonio netto: 30 049 $ in data 30/04/2024

Health Technology

Profilo

Xian Lin Li currently works as a Chairman & Manager at China National Pharmaceutical Industry Corp.
Ltd.

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. CLASS A 0.00%	14/04/2023	20 000 ( 0.00% )	30 049 $	30/04/2024

Società	Posizione	Inizio
China National Pharmaceutical Industry Corp. Ltd. China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China.	Presidente	-

Attive

Inattive

Società quotate in Borsa

Aziende private

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Aziende private	1
China National Pharmaceutical Industry Corp. Ltd. China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China.	Health Technology

Aziende private

Health Technology